May 9 House E&C Health Subcommittee hearing
On Thursday May 9, 2019 the House Energy and Commerce Committee, Health Subcommittee held a hearing on Lowering Prescription Drug Prices: Deconstructing the Drug Supply Chain. In the latter half…
Final Rule Will Require Drug Manufacturers to Disclose Prices in TV Advertisements
Earlier today, HHS issued a Final Rule that will require pharmaceutical manufacturers to disclose the wholesale acquisition cost (“WAC”) in direct-to-consumer TV advertisements for all Medicare and Medicaid covered drugs. …
Court Holds 2019 Reimbursement Cuts for 340B Drugs Unlawful; Remands to HHS for Remedy for 2018 and 2019
On May 6, 2019, the U.S. District Court for the District of Columbia ruled that CMS acted outside its statutory authority in adopting an almost 30% reimbursement cut for Medicare…
340B Ceiling Price Website Update – HRSA to Publish Additional Pricing Data Elements
The Office of Pharmacy Affairs (OPA) recently published an update regarding the 340B ceiling price website. The update announces that HRSA will publish additional pricing data elements in the OPAIS…
HRSA Adopts New RSR Requirements to Include Data on Services Funded by Program Income
HRSA announced changes to the 2019 Ryan White HIV/AIDS Program Services Report (RSR) to require data on patients whose services are funded through Ryan White HIV/AIDS Program (RWHAP) program income…
340B Hospitals Provide More Care to Underserved Populations Than Non-340B Providers
A report prepared for 340B Health and published by L&M Policy Research shows that 340B hospitals care for a greater proportion of the underserved and low-income patient population than non-340B…
Sentry Allowed to Continue Antitrust Lawsuit Against CVS and Wellpartner
Last week, the U.S. District Court for the Southern District of Florida held that Sentry Data Systems Inc. can proceed in an antitrust lawsuit against CVS Pharmacy, Inc., alleging that…
Trump Administration’s 2020 Budget Proposal – Significant Changes to 340B, Global HIV/AIDS Funding, and Medicare and Medicaid
The Trump administration’s fiscal year (FY) 2020 budget request, released on Monday, February 11, includes potentially harmful changes to the 340B program, increased funding for HIV/AIDS (although at the expense…
CANN National 340B Commission Releases Report Calling for Harmful Changes to the 340B Program
This week, a report was released by the Community Access National Network (CANN), an organization created and sponsored by PhRMA and several pharmaceutical manufacturers. The stated goal of the report…
HHS Files Status Report on Publishing of 340B Ceiling Prices
On February 28, 2019, the U.S. Department of Health and Human Services (HHS) filed a status report with the U.S. District Court for the District of Columbia regarding its progress…